Related Experiment Videos
Therapeutic node dissections in malignant melanoma
1State University of New York at Buffalo, Millard Fillmore Health System, 14209, USA.
Seminars in Surgical Oncology
|May 20, 1998
Summary
Therapeutic node dissections for malignant melanoma offer a chance of cure when distant disease is absent. Thorough dissections improve survival rates by eradicating regional disease and preventing recurrence.
Area of Science:
- Oncology
- Surgical Oncology
- Dermatology
Background:
- Therapeutic node dissections are crucial for potentially curative treatment in malignant melanoma patients without distant metastasis.
- Regional nodal basins are key sites for melanoma spread, making lymphadenectomy a critical intervention.
Purpose of the Study:
- To evaluate the role and outcomes of therapeutic node dissections in achieving cure for malignant melanoma.
- To correlate survival rates with the thoroughness of lymphadenectomy and early detection of nodal disease.
Main Methods:
- Review of therapeutic lymphadenectomy procedures for palpable or biopsy-proven positive regional lymph nodes in malignant melanoma.
- Analysis of 5-year survival rates in relation to surgical management and patient follow-up protocols.
Main Results:
- 5-year survival rates after therapeutic lymphadenectomy range from 19% to 38% in historical literature.
- Current survival rates are trending towards the higher end of this spectrum due to improved patient surveillance and early surgical intervention.
- Properly performed dissections have low morbidity and are essential for complete regional disease eradication.
Conclusions:
- Therapeutic node dissections offer the best chance of cure for malignant melanoma in the absence of distant disease.
- Thorough surgical technique is paramount to maximize survival by preventing regional recurrence.
- Close patient follow-up facilitates early detection and treatment of nodal disease, improving overall outcomes.